Operating Segments (Tables)

9 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(Dollars in thousands)	2014			2013			2014			2013
Revenue:
Medical Device	$	10,821		$	10,591		$	31,852		$	30,857
In Vitro Diagnostics		3,795			3,698			10,251			10,978
Total revenue	$	14,616		$	14,289		$	42,103		$	41,835
Operating income:
Medical Device	$	5,855		$	5,223		$	16,466		$	15,848
In Vitro Diagnostics		974			915			2,277			2,933
Total segment operating income		6,829			6,138			18,743			18,781
Corporate		(1,496	)		(1,900	)		(5,601	)		(5,537	)
Total operating income	$	5,333		$	4,238		$	13,142		$	13,244
Depreciation and amortization:
Medical Device	$	281		$	319		$	862		$	947
In Vitro Diagnostics		214			216			641			649
Corporate		179			193			551			578
Total depreciation and amortization	$	674		$	728		$	2,054		$	2,174